Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8349558 | Detection of individual T-cell reaction patterns against tumor-associated antigens (TAA) in tumor patients as a basis for the individual therapeutic vaccination of patients | Martina Fatho, Emmanuelle Wesarg, Volker Lennerz, Pierre van der Bruggen, Serena Debo | 2013-01-08 |
| 6669946 | METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORMALITY SOME OF WHOSE ABNORMAL CELLS PRESENT COMPLEXES OF HUMAN LEUKOCYTE ANTIGEN TYROSINASE DERIVED PEPTIDES, AND METHODS FOR TREATING SAID INDIVIDUALS | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie +2 more | 2003-12-30 |
| 6284476 | Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie +2 more | 2001-09-04 |
| 6201111 | Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors | Vincent Brichard, Aline Van Pel, Catia Traversari, Pierre Coulie, Thierry Boon-Falleur +1 more | 2001-03-13 |
| 6001975 | Precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thierry Boon-Falleur, Etienne De Plaen | 1999-12-14 |
| 5856091 | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Pierre Coulie, Thierry Boon-Falleur +1 more | 1999-01-05 |
| 5854203 | Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thierry Boon-Falleur, Etienne De Plaen | 1998-12-29 |
| 5843687 | Isolated, tyrosinase derived peptides and uses thereof | Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur | 1998-12-01 |
| 5843688 | Isolated tyrosinase derived peptides and uses thereof | Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur, Etienne DePlaen, Pierre Coulie +2 more | 1998-12-01 |
| 5837476 | Methods for determining disorders by assaying for a non-tyrosinase, tumor rejection antigen precursor | Vincent Brichard, Aline Van Pel, Catia Traversari, Thierry Boon-Falleur, Etienne De Plaen | 1998-11-17 |
| 5747271 | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-A2/tyrosinase derived peptides, and methods for treating said individuals | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie +1 more | 1998-05-05 |
| 5744316 | Isolated, tyrosinase derived peptides and uses thereof | Bernard Lethe, Vincent Brichard, Aline Van Pel, Thierry Boon-Falleur | 1998-04-28 |
| 5530096 | Isolated, tyrosinase derived peptides and uses thereof | Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur, Etienne DePlaen, Pierre Coulie +2 more | 1996-06-25 |
| 5519117 | Isolated, tyrosinase derived peptides and uses thereof | Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur | 1996-05-21 |
| 5487974 | Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells | Thierry Boon-Falleur, Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie +2 more | 1996-01-30 |